Sign in
4/A

Changes in Ownership

Attovia Therapeutics, Inc. Filed Acc 0001866174-26-000011

Director bought 585,000 shares at an average $17.58 ($10,285,000)

  • Director sold 105,807 shares at an average $21.28 ($2,251,658)
  • Director acquired 2,435,632 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

WALSH COLIN · Director

Table I: Non-derivative

27 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-05 Purchase : show line 1 in the form +85,000 $21.00 $1,785,000 85,000 I
2026-08-05 Sale : show line 2 in the form −988 $22.03 $21,766 84,012 I
2026-08-05 Sale : show line 3 in the form −447 $21.87 $9,776 83,565 I
2026-08-05 Sale : show line 4 in the form −1,332 $22.03 $29,344 82,233 I
2026-08-05 Sale : show line 5 in the form −200 $22.05 $4,410 82,033 I
2026-08-05 Sale : show line 6 in the form −1,556 $22.06 $34,325 80,477 I
2026-08-05 Sale : show line 7 in the form −3,402 $22.02 $74,912 77,075 I
2026-08-05 Sale : show line 8 in the form −200 $22.10 $4,420 76,875 I
Open-market purchases · 585,000 sh · avg $17.58 · $10,285,000
Open-market sales · 105,807 sh · avg $21.28 · $2,251,658

Table II: Derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-06 Conversion : show line 28 in the form Series B Preferred Stock −18,181,830 0 I
2026-08-06 Conversion : show line 29 in the form Series C Preferred Stock −4,445,275 0 I
2026-08-05 Purchase : show line 30 in the form Equity Swap +2,872 $21.22 $60,944 2,872 I
2026-08-05 Purchase : show line 31 in the form Equity Swap +28,717 $21.22 $609,375 31,589 I
2026-08-05 Purchase : show line 32 in the form Equity Swap +11,488 $21.22 $243,775 43,077 I
2026-08-05 Purchase : show line 33 in the form Equity Swap +45,588 $21.27 $969,657 88,665 I
2026-08-05 Purchase : show line 34 in the form Equity Swap +11,398 $21.27 $242,435 100,063 I
2026-08-05 Purchase : show line 35 in the form Equity Swap +5,744 $21.22 $121,888 105,807 I
Loading xslF345X06/wk-form4a_1787953131.xml…